Related references
Note: Only part of the references are listed.Lung Cancer and Hormone Replacement Therapy: Association in the Vitamins and Lifestyle Study
Christopher G. Slatore et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A Lung Cancer Responding to Hormonal Therapy
Ian M. Collins et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Targeting Aromatase and Estrogen Signaling in Human Non-Small Cell Lung Cancer
Diana C. Marquez-Garban et al.
STEROID ENZYMES AND CANCER (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Hormone Replacement Therapy and Survival in Lung Cancer in Postmenopausal Women in a Rural Population
Bin Huang et al.
CANCER (2009)
Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation
Maria G. Raso et al.
CLINICAL CANCER RESEARCH (2009)
Characteristics of menstruation and pregnancy and the risk of lung cancer in women
Anita Koushik et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial
Rowan T. Chlebowski et al.
LANCET (2009)
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer
Anne M. Traynor et al.
LUNG CANCER (2009)
Hormone use and lung cancer incidence: the Rancho Bernardo cohort study
Joshua R. Smith et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma
Zane Hammoud et al.
ENDOCRINE-RELATED CANCER (2008)
Reproductive factors, hormone use, estrogen receptor expression and risk of non-small-cell lung cancer in women
Ann G. Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Aromatase expression predicts survival in women with early-stage non-small cell lung cancer
Vei Mah et al.
CANCER RESEARCH (2007)
Hormone replacement therapy and lung cancer risk in Chinese
Kuan-Yu Chen et al.
CANCER (2007)
Estrogen receptor signaling pathways in human non-small cell lung cancer
Diana C. Marquez-Garban et al.
STEROIDS (2007)
Hormone replacement therapy as a risk factor for non-small cell lung cancer: Results of a case-control study
N. Ramnath et al.
ONCOLOGY (2007)
Estrogen receptors and human disease
BJ Deroo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Hormone replacement therapy is associated with decreased survival in women with lung cancer
AK Ganti et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Aromatase inhibitors in human lung cancer therapy
OK Weinberg et al.
CANCER RESEARCH (2005)
Nuclear estrogen receptor β in lung cancer:: Expression and survival differences by sex
AG Schwartz et al.
CLINICAL CANCER RESEARCH (2005)
Progesterone receptor in non-small cell lung cancer - A potent prognostic factor and possible target for endocrine therapy
H Ishibashi et al.
CANCER RESEARCH (2005)
Estrogen receptor α and β are prognostic factors in non-small cell lung cancer
H Kawai et al.
CLINICAL CANCER RESEARCH (2005)
Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells
RJ Pietras et al.
STEROIDS (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands
PA Hershberger et al.
CANCER RESEARCH (2005)
A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer - Cancer and Leukemia Group B Study (9235)
EF McClay et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2005)
Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries
F Bray et al.
EUROPEAN JOURNAL OF CANCER (2004)
Hormone replacement therapy and lung cancer risk: A case-control analysis
MB Schabath et al.
CLINICAL CANCER RESEARCH (2004)
Hormonal factors and risk of lung cancer among women?
M Kreuzer et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer
KA Moore et al.
ANNALS OF THORACIC SURGERY (2003)
Estrogen replacement therapy and risk of lung cancer
JA Blackman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue
MJ Fasco et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Mechanisms of disease - Production and actions of estrogens
CJ Gruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends
HL Howe et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α -: A new model for anti-estrogen resistance
RA Campbell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy
YM Chen et al.
LUNG CANCER (2000)
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer
YM Chen et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2000)
Share Paper
